DiaSorin SpA - Company Profile

Powered by

All the data and insights you need on DiaSorin SpA in one report.

$395 $295
Buy Report View Sample
  • Save hours of research time and resources with
    our up-to-date DiaSorin SpA Strategy Report

  • Understand DiaSorin SpA position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

DiaSorin SpA: Overview

Select Item

Related keylists

DiaSorin SpA (DiaSorin) is a medical diagnostics company that is engaged in the development, manufacturwing, and marketing of in vitro diagnostics reagent kits and systems. The company develops reagent kits based on Enzyme Linked Immunosorbent Assays (ELISA) and Chemiluminescence (CLIA) techniques, to enable automatic diagnostic investigation. The company’s immunodiagnostic and molecular diagnostics products find application in the diagnosis of infectious diseases, bone and mineral disorders, endocrinology, hypertension, oncology, gastrointestinal infections, autoimmune disorders, and neurological and cardiac diseases, among others. DiaSorin markets its products through direct sales force and distributors. It has operations in North America, South America, South Africa, Europe, the Middle East, Africa, and Asia. DiaSorin is headquartered in Saluggia, Piemonte, Italy.

 Gain a 360-degree view of DiaSorin SpA and make more informed decisions for your business Gain a 360-degree view of DiaSorin SpA and make more informed decisions for your business Find out more
Headquarters Italy
Address Via Crescentino Snc, Saluggia, 13040
Website www.diasorin.com
Telephone 39 0161 487526
No of Employees 3,278
Industry Medical Equipment
Ticker Symbol & Exchange DIA (BIT)
Revenue (2022) $1.4B 10% (2022 vs 2021)
EPS XYZ
Net Income (2022) XYZ -22.5% (2022 vs 2021)
Market Cap* $5.5B
Net Profit Margin (2022) XYZ -29.6% (2022 vs 2021)
* As of and is in US$
View DiaSorin SpA financials
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

DiaSorin SpA premium industry data and analytics

90+

Medical Pipeline Products

A database of medical devices that are in the process to get approved for sale around the world. Devices that are in development, through to those in the approval process are included.

50+

Medical Clinical Trials

A database of clinical trials planned, currently ongoing, completed, suspended, withdrawn, and terminated in countries around the world.

1

IT Services Contracts

Improve competitive bidding with insights into all publicly disclosed IT services contracts for DiaSorin SpA (including IT outsourcing, business process outsourcing, systems integration & consulting and more).

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on DiaSorin SpA’s likely spend across technology areas enabling you to understand the digital strategy.

Products and Services

Products Brands
- -
Immunodiagnostic Solutions: LIAISON
CLIA Systems: EVOlyzer
XYZ XYZ
XYZ XYZ
XYZ XYZ
Understand DiaSorin SpA portfolio and identify potential areas for collaboration Understand DiaSorin SpA portfolio and identify potential areas for collaboration Find out more

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2023 New Products/Services In July, the company announced the launch of the new LIAISON Legionella Urinary Antigen Immunodiagnostic Assay.
2023 Contracts/Agreements In February, the company through its subsidiary, Luminex Corporation signed an agreement to sell Flow Cytometry and Imaging business to Cytek Biosciences Inc.
2021 Regulatory Approval In November, the company obtained approval from FDA for the QuantiFERON-TB Gold Plus assay for use on DiaSorin’s automated LIAISON XS platform.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Find out more
Image for loader

Competitor Comparison

Key Parameters DiaSorin SpA Thermo Fisher Scientific Inc Danaher Corp Siemens Healthineers AG Becton Dickinson and Co
Headquarters Italy United States of America United States of America Germany United States of America
City Saluggia Waltham Washington Erlangen Franklin Lakes
State/Province - Massachusetts WashingtonD.C. Bayern New Jersey
No. of Employees 3,278 130,000 79,000 70,800 77,000
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Michele Denegri Chairman Executive Board 2022 54
Carlo Rosa General Manager; Chief Executive Officer; Director Executive Board 2019 57
Chen Menachem Even, Ph.D. Director; Chief Commercial Officer Executive Board 2016 60
Piergiorgio Pedron Chief Financial Officer Senior Management 2016 52
Giancarlo Boschetti Deputy Chairman Executive Board 2022 84
Non Dignissim Eros Proin vel Convallis 2023 XY
Non Dignissim Eros Proin vel Convallis 2023 XY
Non Dignissim Eros Proin vel Convallis 2023 XY
Gain insight into DiaSorin SpA key executives to enhance your sales strategy Gain insight into DiaSorin SpA key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward